GlassScriptPhysician profile
Leslie D Rokoske
NPI 1669657227
$1,177.96
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $961 · 2020: $194 · 2021: $22.50.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $212.93 | 2019-2020 | |
| Allergan, INC. | $162.60 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $157.03 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $122.01 | 2019-2020 | |
| Bausch Health US, LLC | $108.43 | 2019 | |
| Shire North American Group INC | $98.07 | 2019 | |
| Neos Therapeutics, LP | $93.74 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $79.33 | 2019-2020 | |
| Adlon Therapeutics L.P. | $45.69 | 2019-2020 | |
| Abbvie INC. | $22.50 | 2021 | |
| Aytu Biopharma, INC. | $21.86 | 2019 | |
| Janssen Pharmaceuticals, INC | $20.43 | 2019 | |
| Avanir Pharmaceuticals, INC. | $16.70 | 2019 | |
| Ironshore Pharmaceuticals INC. | $16.64 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Rokoske listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.